Skip to content

Arvinas ARVN EV / sales

EV / sales at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
22.7×+2.8×
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
130.9×+101×
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
27.8×+26.3×
Immunome logo
ImmunomeIMNM
472×+442×
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
870.6×+479×
Arcus Biosciences logo
Arcus BiosciencesRCUS
11.1×+6.1×

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Calculated from Arvinas’s reported figures.

Based on the most recent quarter.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's EV / sales?
Arvinas (ARVN) reported EV / sales of 6.7× in Q1 2026.
How has Arvinas's EV / sales changed year-over-year?
Arvinas's EV / sales increased by 593.8% year-over-year, from 1× to 6.7×.
What is the long-term trend for Arvinas's EV / sales?
Over 4 years (2020 to 2025), Arvinas's EV / sales has grown at a -64.5% compound annual growth rate (CAGR), from 150.8× to 2.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.